These results mean that the interruption of EGFR signaling by EGFRIs also affects keratin expression, and further studies of other inflammatory keratins, such as K6, K16, and K17, in the lesional skin of patients under EGFRI-induced skin toxicity are needed. This evidence concerns the gene KRT16 and dermatological toxicity.